Leukemia Research

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Leukemia Research is a journal published by Elsevier BV in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,050 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1873-5835 · 0145-2126
Country
United Kingdom
Access
Not open access / not declared
Declared publication charge
4,050 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1979-01-01
  • PUBMED · 2009-02-08
Indexing
MEDLINE · PUBMED
APC
4,050 USD
Declared review time (DOAJ)
—
Actual review time (measured)
86 days received→accepted — computed from PubMed (n=96)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

13651

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

118

i10-index

5055

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
49%
ORCID iDs in current deposits
26%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
7706787
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
Show all subjects (50)
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Retinoids in leukemia and cellular processes
  • Retinoids in leukemia and cellular processes
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Eosinophilic Disorders and Syndromes
  • Eosinophilic Disorders and Syndromes
  • Immunodeficiency and Autoimmune Disorders
  • Immunodeficiency and Autoimmune Disorders
  • Hematological disorders and diagnostics
  • Hematological disorders and diagnostics
  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Histone Deacetylase Inhibitors Research
  • Histone Deacetylase Inhibitors Research
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • T-cell and Retrovirus Studies
  • T-cell and Retrovirus Studies
  • Protein Degradation and Inhibitors
  • Protein Degradation and Inhibitors
  • Blood disorders and treatments
  • Blood disorders and treatments
  • Neutropenia and Cancer Infections
  • Neutropenia and Cancer Infections
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Viral-associated cancers and disorders
  • Viral-associated cancers and disorders
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • CAR-T cell therapy research
  • CAR-T cell therapy research

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: